Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
imfinzi durvalumab iv | 0.42 | 0.2 | 8538 | 68 | 21 |
imfinzi | 1.11 | 0.2 | 2252 | 46 | 7 |
durvalumab | 0.4 | 0.2 | 8679 | 84 | 10 |
iv | 1.6 | 0.6 | 3109 | 64 | 2 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
imfinzi durvalumab iv | 0.55 | 0.1 | 6339 | 21 |
imfinzi durvalumab indications | 1.34 | 0.7 | 976 | 84 |
imfinzi durvalumab side effects | 1.7 | 0.4 | 8540 | 60 |
imfinzi durvalumab cost | 0.73 | 0.1 | 7911 | 58 |
imfinzi durvalumab biggest company | 0.67 | 0.6 | 6586 | 86 |
imfinzi durvalumab biggest controversy | 0.4 | 0.9 | 1240 | 45 |
imfinzi durvalumab biggest cost | 1.79 | 0.9 | 2228 | 76 |
imfinzi durvalumab biggest comparison | 0.1 | 0.3 | 410 | 49 |
imfinzi durvalumab biggest competitor | 0.67 | 0.3 | 9797 | 2 |
imfinzi durvalumab biggest customer | 0.9 | 0.9 | 9470 | 56 |
imfinzi durvalumab biggest challenge | 0.59 | 0.6 | 3941 | 16 |
imfinzi durvalumab biggest collaboration | 0.75 | 0.2 | 9162 | 33 |
imfinzi durvalumab biggest clinical trial | 1.3 | 1 | 2743 | 79 |
imfinzi durvalumab biggest competitor in cost | 1.59 | 0.3 | 8965 | 80 |
imfinzi durvalumab biggest commercial | 1.22 | 0.3 | 8087 | 45 |